Vaxcyte is re-engineering the way highly complex vaccines are made through XpressCF®, its cell-free protein synthesis platform
GlobeNewswire public company news · 2026-10-07 10:48
查看证据
- 公司披露GlobeNewswire public company news2026-10-07 10:48
Vaxcyte is re-engineering the way highly complex vaccines are made through XpressCF®, its cell-free protein synthesis platform
查看来源 - 公司披露GlobeNewswire public company news2026-10-07 10:48
Vaxcyte’s system for producing difficult-to-make proteins and antigens is intended to develop and deliver high-fidelity vaccines
查看来源